Literature DB >> 18299321

Protein phosphatase 2A is a negative regulator of transforming growth factor-beta1-induced TAK1 activation in mesangial cells.

Sung Il Kim1, Joon Hyeok Kwak, Lin Wang, Mary E Choi.   

Abstract

TAK1 (transforming growth factor (TGF)-beta-activated kinase 1) is a serine/threonine kinase that is rapidly activated by TGF-beta1 and plays a vital function in its signal transduction. Once TAK1 is activated, efficient down-regulation of TAK1 activity is important to prevent excessive TGF-beta1 responses. The regulatory mechanism of TAK1 inactivation following TGF-beta1 stimulation has not been elucidated. Here we demonstrate that protein phosphatase 2A (PP2A) plays a pivotal role as a negative regulator of TAK1 activation in response to TGF-beta1 in mesangial cells. Treatment with okadaic acid (OA) induces autophosphorylation of Thr-187 in the activation loop of TAK1. In vitro dephosphorylation assay suggests that Thr-187 in TAK1 is a major dephosphorylation target of PP2A. TGF-beta1 stimulation rapidly activates TAK1 in a biphasic manner, indicating that TGF-beta1-induced TAK1 activation is tightly regulated. The association of PP2A(C) with TAK1 is enhanced in response to TGF-beta1 stimulation and closely parallels TGF-beta1-induced TAK1 activity. Attenuation of PP2A activity by OA treatment or targeted knockdown of PP2A(C) with small interfering RNA enhances TGF-beta1-induced phosphorylation of TAK1 at Thr-187 and MKK3 (MAPK kinase 3). Endogenous TAK1 co-precipitates with PP2A(C) but not PP6(C), another OA-sensitive protein phosphatase, and knockdown of PP6(C) by small interfering RNA does not affect TGF-beta1-induced phosphorylation of TAK1 at Thr-187 and MKK3. Moreover, ectopic expression of phosphatase-deficient PP2A(C) enhances TAK1-mediated MKK3 phosphorylation by TGF-beta1 stimulation, whereas the expression of wild-type PP2A(C) suppresses the MKK3 phosphorylation. Taken together, our data indicate that PP2A functions as a negative regulator in TGF-beta1-induced TAK1 activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299321      PMCID: PMC2447645          DOI: 10.1074/jbc.M801263200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  TAK1 MAPK kinase kinase mediates transforming growth factor-beta signaling by targeting SnoN oncoprotein for degradation.

Authors:  Taisuke Kajino; Emily Omori; Shunsuke Ishii; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2007-02-02       Impact factor: 5.157

Review 2.  Physiologic importance of protein phosphatase inhibitors.

Authors:  C J Oliver; S Shenolikar
Journal:  Front Biosci       Date:  1998-09-01

3.  TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen.

Authors:  Sung Il Kim; Joon Hyeok Kwak; Mareena Zachariah; Yanjuan He; Lin Wang; Mary E Choi
Journal:  Am J Physiol Renal Physiol       Date:  2007-02-13

4.  Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters.

Authors:  C J Hastie; P T Cohen
Journal:  FEBS Lett       Date:  1998-07-24       Impact factor: 4.124

5.  Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway.

Authors:  Taisuke Kajino; Hong Ren; Shun-Ichiro Iemura; Tohru Natsume; Bjarki Stefansson; David L Brautigan; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2006-11-01       Impact factor: 5.157

6.  TAB3, a new binding partner of the protein kinase TAK1.

Authors:  Peter C F Cheung; Angel R Nebreda; Philip Cohen
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

7.  HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81.

Authors:  Sean C Dowdy; Andrea Mariani; Ralf Janknecht
Journal:  J Biol Chem       Date:  2003-08-28       Impact factor: 5.157

8.  Identification of a human NF-kappaB-activating protein, TAB3.

Authors:  Ge Jin; Alison Klika; Michelle Callahan; Ben Faga; Joel Danzig; Zhengfan Jiang; Xiaoxia Li; George R Stark; John Harrington; Bruce Sherf
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

9.  Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling.

Authors:  Tohru Ishitani; Giichi Takaesu; Jun Ninomiya-Tsuji; Hiroshi Shibuya; Richard B Gaynor; Kunihiro Matsumoto
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

Review 10.  TGF-beta signal transduction.

Authors:  J Massagué
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

View more
  33 in total

1.  Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation.

Authors:  Yihui Fan; Yi Shi; Shangfeng Liu; Renfang Mao; Lei An; Yanling Zhao; Hong Zhang; Fuchun Zhang; Guotong Xu; Jun Qin; Jianhua Yang
Journal:  Cell Signal       Date:  2012-03-03       Impact factor: 4.315

2.  BAT3 interacts with transforming growth factor-beta (TGF-beta) receptors and enhances TGF-beta1-induced type I collagen expression in mesangial cells.

Authors:  Joon Hyeok Kwak; Sung Il Kim; Jin Kuk Kim; Mary E Choi
Journal:  J Biol Chem       Date:  2008-05-16       Impact factor: 5.157

3.  Transforming growth factor (TGF)-β-activated kinase 1 (TAK1) activation requires phosphorylation of serine 412 by protein kinase A catalytic subunit α (PKACα) and X-linked protein kinase (PRKX).

Authors:  Chuan Ouyang; Li Nie; Meidi Gu; Ailing Wu; Xu Han; Xiaojian Wang; Jianzhong Shao; Zongping Xia
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

4.  FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.

Authors:  Jen-Liang Su; Xiaoyun Cheng; Hirohito Yamaguchi; Yi-Wen Chang; Chao-Feng Hou; Dung-Fang Lee; How-Wen Ko; Kuo-Tai Hua; Ying-Nai Wang; Michael Hsiao; Poshen B Chen; Jung-Mao Hsu; Robert C Bast; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Res       Date:  2011-09-12       Impact factor: 12.701

5.  The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation.

Authors:  Masahiro Okada; Atsushi Matsuzawa; Akihiko Yoshimura; Hidenori Ichijo
Journal:  J Biol Chem       Date:  2014-10-06       Impact factor: 5.157

Review 6.  TAK1 control of cell death.

Authors:  S R Mihaly; J Ninomiya-Tsuji; S Morioka
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

Review 7.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

8.  TIPE2 (Tumor Necrosis Factor α-induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal.

Authors:  Michitaka Oho; Risa Nakano; Ryutarou Nakayama; Wataru Sakurai; Azusa Miyamoto; Yoshikazu Masuhiro; Shigemasa Hanazawa
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

9.  Transforming growth factor beta-activated kinase 1 (TAK1) kinase adaptor, TAK1-binding protein 2, plays dual roles in TAK1 signaling by recruiting both an activator and an inhibitor of TAK1 kinase in tumor necrosis factor signaling pathway.

Authors:  Peter Broglie; Kunihiro Matsumoto; Shizuo Akira; David L Brautigan; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

Review 10.  TGF-β signaling via TAK1 pathway: role in kidney fibrosis.

Authors:  Mary E Choi; Yan Ding; Sung Il Kim
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.